The role of growth factors on renal tubular cells submitted to hypoxia and deprived of glucose

被引:16
作者
Durao, MD [1 ]
Razvickas, CV [1 ]
Gonçalves, EAP [1 ]
Okano, IR [1 ]
Camargo, SMR [1 ]
Monte, JCM [1 ]
dos Santos, OFP [1 ]
机构
[1] Univ Fed Sao Paulo, Div Nephrol, Escola Paulista Med, Sao Paulo, Brazil
关键词
ARF; growth factors; apoptosis; renal tubular cells; hypoxia;
D O I
10.1081/JDI-120021149
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. In acute renal failure (ARF) renal tubular cell death and detachment can be induced by necrotic and apoptotic mechanisms. Several studies have demonstrated some benefits of the use of growth factors in experimental models of ARF. Methods. MDCK cells were cultured in a glucose-free medium for 24 h and were submitted to hypoxia (pO(2) around 35 mmHg) for additional 24 h. To evaluate the possible protective role of growth factors, EGF, IGF-I or HGF were added to the medium (20 ng mL). LDH release, viability (acridine orange and ethidium bromide dyes) and quantification of apoptotic cells (Hoechst 33342 dye fluorescence) were determined. Results. In the injury group, an increase on LDH release (60% vs. 3%) and on number of apoptotic cells (22% vs. 0.2%) which was associated with a reduced cell viability (61% vs. 94%) when compared with controls. Only HGF, not EGF or IGF-I, was able to protect cells from injury. HGF caused a significant reduction on LDH release (30%) and on number of apoptotic cells (5%), with an increase on viability cellular (79%). Conclusions. HGF decreases cell death on MDCK cells after hypoxic-induced injury, probably acting in both necrotic and apoptotic mechanisms.
引用
收藏
页码:341 / 353
页数:13
相关论文
共 27 条
[1]  
ARDAILLOU R, 1996, KIDNEY, P99
[2]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[3]  
Beutler E., 1971, Red Cell Metabolism
[4]   MECHANISMS OF ISCHEMIC ACUTE-RENAL-FAILURE [J].
BONVENTRE, JV .
KIDNEY INTERNATIONAL, 1993, 43 (05) :1160-1178
[5]  
BREZIS M, 1993, ACUTE RENAL FAILURE, P207
[6]  
Cotter T.G., 1996, TECHNIQUES APOPTOSIS
[7]  
Hirschberg R, 1998, SEMIN NEPHROL, V18, P191
[8]   Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure [J].
Hirschberg, R ;
Kopple, J ;
Lipsett, P ;
Benjamin, E ;
Minei, J ;
Albertson, T ;
Munger, M ;
Metzler, M ;
Zaloga, G ;
Murray, M ;
Lowry, S ;
Conger, J ;
McKeown, W ;
O'Shea, M ;
Baughman, R ;
Wood, K ;
Haupt, M ;
Kaiser, R ;
Simms, H ;
Warnock, D ;
Summer, W ;
Hintz, R ;
Myers, B ;
Haenftling, K ;
Capra, W ;
Pike, M ;
Guler, HP .
KIDNEY INTERNATIONAL, 1999, 55 (06) :2423-2432
[9]   EPIDERMAL GROWTH-FACTOR ENHANCES RENAL TUBULE CELL REGENERATION AND REPAIR AND ACCELERATES THE RECOVERY OF RENAL-FUNCTION IN POSTISCHEMIC ACUTE RENAL-FAILURE [J].
HUMES, HD ;
CIESLINSKI, DA ;
COIMBRA, TM ;
MESSANA, JM ;
GALVAO, C .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1757-1761
[10]   HEPATOCYTE GROWTH-FACTOR MAY FUNCTION AS A RENOTROPIC FACTOR FOR REGENERATION IN RATS WITH ACUTE RENAL INJURY [J].
IGAWA, T ;
MATSUMOTO, K ;
KANDA, S ;
SAITO, Y ;
NAKAMURA, T .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01) :F61-F69